Event Type: Conference Call for Investors and Analysts to discuss quarterly financial results
Date and Time: Wednesday, 5 August 2026 at 6:30 P.M. IST
Purpose: Discussion of the Unaudited Financial Results of the Company for the Quarter ended 30 June 2026 (Q1 FY27)
Earnings Announcement Timing: The financial results will be announced earlier on the same day (5 August 2026) prior to the conference call
Event Format: The conference call will be initiated with a brief management discussion on the Q1 FY27 results followed by an interactive Question & Answer session
Management Participants: The senior management of Cohance Lifesciences Ltd. will participate in the Conference Call
Compliance Statement: The company has indicated that no unpublished price sensitive information (UPSI) will be shared during the call
Additional Notes Section
Contact Information Provided:
- Cyndrella Carvalho, Head - Investor Relations, Cohance Lifesciences Limited
- Tel: 040 2354 3311
- Gavin Desa, CDR India
- Tel: +91 98206 37649
Dial-in Information: Multiple international toll-free numbers provided for Singapore, Hong Kong, USA, and UK, plus primary India numbers (+91 22 6280 1141 / +91 22 7115 8042)
Pre-registration Requirement: Participants are encouraged to pre-register to receive dial-in numbers, passcode, and pin for the conference call
No Financial Data Disclosed: This announcement contains no financial figures or performance metrics for Q1 FY27